Skip to main content
Premium Trial:

Request an Annual Quote

Stephen David, Sunny Tam, Douglas Hinerfeld, Will Brooke, Mark Grovic, Ofer Haviv, Martin Gerstel, Leon Recanati, and Ilan Chet

Premium

Stephen David has joined Nonlinear Dynamics' strategic marketing team, the Newcastle upon Tyne, UK-based company said this week. He comes to Nonlinear from GE Healthcare, formerly Amersham Biosciences, where he worked as DiGE global applications specialist.


Sunny Tam (see Proteomics Pioneer) has joined the University of Massachusetts Medical School as research associate professor, and Douglas Hinerfeld as research assistant professor, both of biochemistry and molecular pharmacology, UMMS said last week. The two researchers come to UMMS from Charles River Proteomic Services, which closed down last year. They will participate in running the new UMMS Proteomic Consortium (see UMMS story).


Will Brooke and Mark Grovic have joined the board of directors of pathogen detection firm Innovative Biosensors of College Park, Md., in conjunction with the company's recent Series A round, Innovative said last week. Brooke works for Harbert Venture Partners and Grovic for New Markets Growth Fund, both investors in the financing round.


Ofer Haviv has been promoted to president and chief executive officer of Evogene, the Rehovot, Israel-based company, a subsidiary of Compugen, said yesterday. He used to be the company's chief operating and financial officer. He replaces Hagai Karchi, who has switched to the position of chief scientific officer.

In addition, Martin Gerstel, chairman of Compugen, has been appointed chairman of Evogene's board of directors. Leon Recanati, chairman and CEO of GlenRock Israel, has been elected as director, and Ilan Chet, president of the Weizmann Institute, as a special advisor to the company's board.

 

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.